Novel therapeutic targets and agents for pediatric dyslipidemia
Landmark studies have convincingly demonstrated that atherosclerosis begins in youth. While generally asymptomatic, an increasing number of youth with disorders of lipid and lipoprotein metabolism, such as familial hypercholesterolemia, are being identified through selective and universal screening....
Guardado en:
Autores principales: | Bhuvana Sunil, Christy Foster, Don P. Wilson, Ambika P. Ashraf |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2e65083e79b2421a91972ca99f34a5a3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Reenvisioning Traditional to Regenerative Therapeutic Advances in Managing Nonalcoholic Fatty Liver Disease in Diabetes Mellitus
por: Lung-Wen Tsai, et al.
Publicado: (2021) -
Identification of Novel GCK and HNF4α Gene Variants in Japanese Pediatric Patients with Onset of Diabetes before 17 Years of Age
por: Rumi Katashima, et al.
Publicado: (2021) -
A Case Report of Subacute Thyroiditis following mRNA COVID-19 Vaccine
por: Leidy Plaza-Enriquez, et al.
Publicado: (2021) -
Immunoglobulin-negative fibrillary glomerulonephritis masked in diabetic nephropathy: A case report and discussion of a diagnostic pitfall.
por: Gabriel B.W. Lerner, et al.
Publicado: (2021) -
Polymorphisms in Genes of Lipid Metabolism Are Associated with Type 2 Diabetes Mellitus and Periodontitis, as Comorbidities, and with the Subjects’ Periodontal, Glycemic, and Lipid Profiles
por: Ingra G. Nicchio, et al.
Publicado: (2021)